Quick Answer
Microbot Medical Inc. reported Cash And Cash Equivalents At Carrying Value of $3.91 million for the year ending 2025.
- Microbot Medical Inc. showed an increase of +25.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), Microbot Medical Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 87.0%.
- Historical annual values: Fiscal year 2025: $3.91 million | Fiscal year 2024: $3.11 million | Fiscal year 2023: $2.47 million | Fiscal year 2022: $2.44 million | Fiscal year 2021: $13.49 million | Fiscal year 2020: $19.65 million | Fiscal year 2019: $28.77 million | Fiscal year 2018: $5.24 million | Fiscal year 2017: $10.79 million | Fiscal year 2016: $2.71 million | Fiscal year 2015: $437.0 thousand | Fiscal year 2014: $791.0 thousand | Fiscal year 2013: $30.59 million | Fiscal year 2012: $8.47 million | Fiscal year 2011: $13.31 million | Fiscal year 2010: $19.71 million | Fiscal year 2009: $38.62 million | Fiscal year 2008: $30.04 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: